129 related articles for article (PubMed ID: 36208044)
1. Serum IgG4 level for malignancy prediction in indeterminate thyroid nodules among patients with or without autoimmune thyroid disease.
Elshaer RK; Halawa MR; Ahmed IZ; Aboelezz NF; Mohamed NR; Bahaa Eldin AM
Egypt J Immunol; 2022 Oct; 29(4):156-162. PubMed ID: 36208044
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of fine-needle aspiration cytopathology to differentiate malignant and benign thyroid nodules with ≥4 cm diameter: A retrospective study.
Rastegar H; Torshizian A; Yaghoubi MA; Khoshhal N; Asadi M; Morovatdar N; Mohebbi M
Diagn Cytopathol; 2023 Apr; 51(4):263-269. PubMed ID: 36585850
[TBL] [Abstract][Full Text] [Related]
3. Shear wave elastography and Afirma™ gene expression classifier in thyroid nodules with indeterminate cytology: a comparison study.
Azizi G; Keller JM; Mayo ML; Piper K; Puett D; Earp KM; Malchoff CD
Endocrine; 2018 Mar; 59(3):573-584. PubMed ID: 29350311
[TBL] [Abstract][Full Text] [Related]
4. Association of Thyroid Nodule Size and Bethesda Class With Rate of Malignant Disease.
Magister MJ; Chaikhoutdinov I; Schaefer E; Williams N; Saunders B; Goldenberg D
JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1089-95. PubMed ID: 26292176
[TBL] [Abstract][Full Text] [Related]
5. Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology.
Yaprak Bayrak B; Eruyar AT
BMC Endocr Disord; 2020 Apr; 20(1):48. PubMed ID: 32293401
[TBL] [Abstract][Full Text] [Related]
6. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
[TBL] [Abstract][Full Text] [Related]
7. Correlation of thyroid fine-needle aspiration with final histopathology: a case series.
Gürkan Dumlu E; Kiyak G; Bozkurt B; Tokaç M; Polat B; Cakir B; Güler G; Kiliç M
Minerva Chir; 2013 Apr; 68(2):191-7. PubMed ID: 23612233
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy and the sonographic differences between benign and malignant thyroid nodules 3 cm or larger.
Yoon JH; Kwak JY; Moon HJ; Kim MJ; Kim EK
Thyroid; 2011 Sep; 21(9):993-1000. PubMed ID: 21834673
[TBL] [Abstract][Full Text] [Related]
9. Thyroid imaging reporting and data system in assessment of cytological Bethesda Category III thyroid nodules.
Mao F; Xu HX; Zhao CK; Bo XW; Li XL; Li DD; Liu BJ; Zhang YF; Xu JM; Qu S
Clin Hemorheol Microcirc; 2017; 65(2):163-173. PubMed ID: 27589516
[TBL] [Abstract][Full Text] [Related]
10. Malignancy is associated with microcalcification and higher AP/T ratio in ultrasonography, but not with Hashimoto's thyroiditis in histopathology in patients with thyroid nodules evaluated as Bethesda Category III (AUS/FLUS) in cytology.
Topaloglu O; Baser H; Cuhaci FN; Sungu N; Yalcin A; Ersoy R; Cakir B
Endocrine; 2016 Oct; 54(1):156-168. PubMed ID: 27172917
[TBL] [Abstract][Full Text] [Related]
11. An innovative synthetic support for immunocytochemical assessment of cytologically indeterminate (Bethesda III) thyroid nodules.
Taccogna S; Papini E; Novizio R; D'Angelo M; Turrini L; Persichetti A; Pontecorvi A; Guglielmi R
Front Endocrinol (Lausanne); 2022; 13():1078019. PubMed ID: 36531453
[TBL] [Abstract][Full Text] [Related]
12. The Mcgill thyroid nodule score - does it help with indeterminate thyroid nodules?
Varshney R; Forest VI; Mascarella MA; Zawawi F; Rochon L; Hier MP; Mlynarek A; Tamilia M; Payne RJ
J Otolaryngol Head Neck Surg; 2015 Feb; 44(1):2. PubMed ID: 25645364
[TBL] [Abstract][Full Text] [Related]
13. Utility of a multigene testing for preoperative evaluation of indeterminate thyroid nodules: A prospective blinded single center study in China.
Song Y; Xu G; Ma T; Zhu Y; Yu H; Yu W; Wei W; Wang T; Zhang B
Cancer Med; 2020 Nov; 9(22):8397-8405. PubMed ID: 32976686
[TBL] [Abstract][Full Text] [Related]
14. Impact of Afirma gene expression classifier on cytopathology diagnosis and rate of thyroidectomy.
Sacks WL; Bose S; Zumsteg ZS; Wong R; Shiao SL; Braunstein GD; Ho AS
Cancer Cytopathol; 2016 Oct; 124(10):722-728. PubMed ID: 27347838
[TBL] [Abstract][Full Text] [Related]
15. The clinical significance of the American College of Radiology (ACR) Thyroid Imaging Reporting and Data System (TI-RADS) category 5 thyroid nodules: Not as risky as we think?
Wright K; Brandler TC; Fisher JC; Rothberger GD; Givi B; Prescott J; Suh I; Patel KN
Surgery; 2023 Jan; 173(1):239-245. PubMed ID: 36511283
[TBL] [Abstract][Full Text] [Related]
16. Fine needle aspiration of the thyroid: correlation with final histopathology in a surgical series of 797 patients.
Lew JI; Snyder RA; Sanchez YM; Solorzano CC
J Am Coll Surg; 2011 Jul; 213(1):188-94; discussion 194-5. PubMed ID: 21601489
[TBL] [Abstract][Full Text] [Related]
17. Quantitative dual isotope
Benderradji H; Beron A; Wémeau JL; Carnaille B; Delcroix L; Do Cao C; Baillet C; Huglo D; Lion G; Boury S; Cussac JF; Caiazzo R; Pattou F; Leteurtre E; Vantyghem MC; Ladsous M
Ann Endocrinol (Paris); 2021 Apr; 82(2):83-91. PubMed ID: 33727116
[TBL] [Abstract][Full Text] [Related]
18. The impact of benign gene expression classifier test results on the endocrinologist-patient decision to operate on patients with thyroid nodules with indeterminate fine-needle aspiration cytopathology.
Duick DS; Klopper JP; Diggans JC; Friedman L; Kennedy GC; Lanman RB; McIver B
Thyroid; 2012 Oct; 22(10):996-1001. PubMed ID: 22873825
[TBL] [Abstract][Full Text] [Related]
19. Association of Hashimoto's thyroiditis with thyroid cancer.
Azizi G; Keller JM; Lewis M; Piper K; Puett D; Rivenbark KM; Malchoff CD
Endocr Relat Cancer; 2014; 21(6):845-52. PubMed ID: 25217233
[TBL] [Abstract][Full Text] [Related]
20. Risk stratification of thyroid nodules with Bethesda category III results on fine-needle aspiration cytology: The additional value of acoustic radiation force impulse elastography.
Zhao CK; Xu HX; Xu JM; Sun CY; Chen W; Liu BJ; Bo XW; Wang D; Qu S
Oncotarget; 2017 Jan; 8(1):1580-1592. PubMed ID: 27906671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
